ESMO 2019 Highlights in HR+ HER2− advanced breast cancer: The MONALEESA-3 study
Michelino De Laurentiis reports on key results from ESMO Congress 2019 on LBA7_PR: Overall survival (OS) results of the Phase III MONALEESA-3 trial...
1 view
1261
356
9 months ago
00:08:49
1
2019-09-08 нед. 12-я Проповедь о. Александра Сорокина на (Мф 19, 16-26):
10 months ago
00:01:19
1
Святое Письмо от Иоанна
1 year ago
00:13:41
1
Debate: Complete Response in Rectal Cancer? - Watchful Waiting
2 years ago
00:39:15
3
Visions of Atlantis 07Feb2023 4K60 HQ audio - epic, dramatic and all that! @1720, Los Angeles 90021
2 years ago
00:20:03
1
Медитация в секторе “Алхимической трансмутации в бассейнах Фиолетового пламени“
4 years ago
00:04:02
1
#ESMO19: Lenvatinib (LEN) and Pembrolizumab (PEMBRO) in Advanced Endometrial Cancer
4 years ago
00:10:58
1
Health-related quality of life for patients with metastatic pancreatic cancer: Updates from ESMO...
5 years ago
00:06:08
2
Период энергий РАССЛОЕНИЕ ЭНЕРГИЙ
5 years ago
00:25:16
1
Исследования, изменившие подходы в лечении гормонозависимого рака молочной железы
5 years ago
00:02:19
1
ESMO 2019 Highlights in HR+ HER2− advanced breast cancer: The MONALEESA-3 study
5 years ago
00:04:17
27
Этого не было (prod. by ESMO)
Back to Top